Cargando…

A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors

Exatecan (Exa) is a very potent inhibitor of topoisomerase I and anticancer agent. It has been intensively studied as a single agent, a large macromolecular conjugate and as the payload component of antigen-dependent antibody–drug conjugates. The current work describes an antigen-independent conjuga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontaine, Shaun D., Carreras, Christopher W., Reid, Ralph R., Ashley, Gary W., Santi, Daniel V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208276/ https://www.ncbi.nlm.nih.gov/pubmed/37377899 http://dx.doi.org/10.1158/2767-9764.CRC-22-0517

Ejemplares similares

A long-acting C-natriuretic peptide for achondroplasia
por: Schneider, Eric L., et al.
Publicado: (2022)

Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy
por: Cheng, Zhiyang, et al.
Publicado: (2021)

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
por: Conilh, Louise, et al.
Publicado: (2021)

A very long-acting IL-15: implications for the immunotherapy of cancer
por: Hangasky, John A, et al.
Publicado: (2022)

A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules
por: Machinaga, Nobuo, et al.
Publicado: (2018)

Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors
por: Grimley, Edward, et al.
Publicado: (2021)

The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects
por: Shen, Hong-Yuan, et al.
Publicado: (2022)

Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair
por: Croglio, Michael P., et al.
Publicado: (2016)

The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
por: Kerl, Kornelius, et al.
Publicado: (2013)

Synergic Effect of Genistein and Daidzein on UVB-Induced DNA Damage: An Effective Photoprotective Combination
por: Iovine, Barbara, et al.
Publicado: (2011)

DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
por: Xiao, Xiao, et al.
Publicado: (2018)

DNA damage repair kinase DNA‐PK and cGAS synergize to induce cancer‐related inflammation in glioblastoma
por: Taffoni, Clara, et al.
Publicado: (2022)

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
por: Rabinowicz, Noa, et al.
Publicado: (2017)

Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity
por: Chang, Mingxin, et al.
Publicado: (2020)

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Veppil Muralidharan, Somsundar, et al.
Publicado: (2017)

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Muralidharan, Somsundar Veppil, et al.
Publicado: (2017)

Quercetin inhibits Toxoplasma gondii tachyzoite proliferation and acts synergically with azithromycin
por: Abugri, Daniel A., et al.
Publicado: (2023)

Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus
por: Walther, Elisabeth, et al.
Publicado: (2016)

EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells
por: Wu, Wenbing, et al.
Publicado: (2021)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity
por: Ovejero-Sánchez, María, et al.
Publicado: (2022)

Damage to hepatic cellular membranes by chlorinated olefins with emphasis on synergism and antagonism.
por: Reynolds, E S, et al.
Publicado: (1977)

Pharmacological interactions: Synergism, or not synergism, that is the question
por: Calzetta, Luigino, et al.
Publicado: (2021)

Engineering potent long-acting variants of the Wnt inhibitor DKK2
por: Sopko, Richelle, et al.
Publicado: (2017)

DAZAP2 acts as specifier of the p53 response to DNA damage
por: Liebl, Magdalena C, et al.
Publicado: (2021)

The promise of DNA damage response inhibitors for the treatment of glioblastoma
por: Majd, Nazanin K, et al.
Publicado: (2021)

Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1
por: Gendarme, Mathieu, et al.
Publicado: (2017)

Rad5 Template Switch Pathway of DNA Damage Tolerance Determines Synergism between Cisplatin and NSC109268 in Saccharomyces cerevisiae
por: Jain, Dilip, et al.
Publicado: (2013)

All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage
por: Xu, Zhifei, et al.
Publicado: (2016)

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer
por: Nieto-Jimenez, Cristina, et al.
Publicado: (2020)

Inactivation of the tumor suppressor gene Apc synergizes with H. pylori to induce DNA damage in murine gastric stem and progenitor cells
por: He, Jiazhuo, et al.
Publicado: (2023)

DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors
por: Folly-Kossi, Helena, et al.
Publicado: (2023)

DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer
por: Velic, Denis, et al.
Publicado: (2015)

DAMPs Synergize with Cytokines or Fibronectin Fragment on Inducing Chondrolysis but Lose Effect When Acting Alone
por: Ding, Lei, et al.
Publicado: (2017)

SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Zhou, Jiyu, et al.
Publicado: (2020)

EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA
por: Valinciute, Gintvile, et al.
Publicado: (2021)

WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma
por: de Jong, Mathilde R. W., et al.
Publicado: (2020)

BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma
por: Gusyatiner, Olga, et al.
Publicado: (2021)

Evaluating very high energy electron RBE from nanodosimetric pBR322 plasmid DNA damage
por: Small, K L, et al.
Publicado: (2021)

Evaluating very high energy electron RBE from nanodosimetric pBR322 plasmid DNA damage
por: Small, K. L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6jkmrh35c89godvof8iuqkns3